Dr. Stephen Bagley, MD
Claim this profileUniversity of Pennsylvania
Studies Brain Tumor
Studies Glioblastoma
8 reported clinical trials
14 drugs studied
Area of expertise
1Brain Tumor
1p/19q codeletion positive
IDH positive
H3 K27M positive
2Glioblastoma
MET positive
EGFR positive
MET negative
Affiliated Hospitals
Clinical Trials Stephen Bagley, MD is currently running
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
ATRA + PD-1 Inhibitor
for Brain Tumor
This trial tests a combination of a vitamin A derivative and an immune-boosting drug in patients with recurring brain tumors. The treatment aims to normalize cancer cell behavior and enhance the immune system's ability to fight the tumor.
Recruiting1 award Phase 25 criteria
More about Stephen Bagley, MD
Clinical Trial Related8 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Stephen Bagley, MD has experience with
- ONC201
- Abemaciclib
- CART-EGFR-IL13Ra2 Cells
- All-trans Retinoic Acid
- Retifanlimab
- Brain Surgery
Breakdown of trials Stephen Bagley, MD has run
Brain Tumor
Glioblastoma
Oligodendroblastoma
Protoplasmic Astrocytoma
Isocitrate Dehydrogenase
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen Bagley, MD specialize in?
Stephen Bagley, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved 1p/19q codeletion positive patients, or patients who are IDH positive.
Is Stephen Bagley, MD currently recruiting for clinical trials?
Yes, Stephen Bagley, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Stephen Bagley, MD has studied deeply?
Yes, Stephen Bagley, MD has studied treatments such as ONC201, Abemaciclib, CART-EGFR-IL13Ra2 Cells.
What is the best way to schedule an appointment with Stephen Bagley, MD?
Apply for one of the trials that Stephen Bagley, MD is conducting.
What is the office address of Stephen Bagley, MD?
The office of Stephen Bagley, MD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.